有机硫化合物是指含有硫原子的有机化合物。这些化合物在自然界中广泛存在,在医药、农药和材料科学等领域有着重要的应用。有机硫化合物因其化学性质独特,在药物设计、合成化学以及材料制备方面扮演着重要角色。
1. 结构与分类有机硫化合物可以按硫的连接方式分为饱和和不饱和类,如二硫化物、噻吩衍生物、砜等。常见的结构类型有:
许多有机硫化合物在生物学上有重要功能或应用潜力。例如:
有机硫化合物可通过多种途径合成:
有机硫化合物的应用广泛:
尽管有机硫化合物具有许多潜在益处,但其生产和使用也可能对环境造成影响。因此,在设计和合成这些化合物时需要考虑可持续性和环保性因素。
以上是对有机硫化合物的简单介绍,包括它们的结构、生物学活性、合成方法及其应用领域等基本信息。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
—— | (2S)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-N-(2,2,2-trifluoroethyl)propanamide | —— | C9H11F3N2OS2 |
|
—— | N-cyclohexyl-N-methyl-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H27N3O2S |
|
—— | 2-[(1R)-1-(2-chlorophenyl)ethyl]sulfanyl-1,3,4-thiadiazole | —— | C10H9ClN2S2 |
|
—— | N-[(1S)-1-cyano-1-cyclopropylethyl]-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H22N4O2S |
|
—— | N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C21H22FN3O2S |
|
—— | 2-(2-ethoxyethylsulfanyl)-5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C15H20N2O2S |
|
—— | 2-(2-methylprop-2-enylsulfanyl)-5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C15H18N2OS |
|
—— | N-ethyl-N-(2-methylprop-2-enyl)-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H25N3O2S |
|
—— | 3-Chloro-4-naphthalen-1-ylsulfanylaniline | —— | C16H12ClNS |
|
—— | (2S)-2-(2,5-dimethylphenyl)sulfanyl-N-(2,2,2-trifluoroethyl)propanamide | —— | C13H16F3NOS |
|
—— | N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C21H22FN3O2S |
|
—— | 3-(2-ethoxyethylsulfanyl)-4-[[(2R)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C11H19N3O3S |
|
—— | (2R)-2-(3,4-dimethylphenyl)sulfanyl-N-(2,2,2-trifluoroethyl)propanamide | —— | C13H16F3NOS |
|
—— | (2S)-N-cyclopentyl-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C19H25N3O2S |
|
—— | (2R)-N-cyclopentyl-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C19H25N3O2S |
|
—— | (2R)-2-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-N-(2,2,2-trifluoroethyl)propanamide | —— | C9H11F3N2OS2 |
|
—— | 1-[(2R,6R)-2,6-dimethylmorpholin-4-yl]-2-(3,4-dimethylphenyl)sulfanylethanone | —— | C16H23NO2S |
|
—— | 1-[(2R,6R)-2,6-dimethylmorpholin-4-yl]-2-(2,4-dimethylphenyl)sulfanylethanone | —— | C16H23NO2S |
|
—— | N-(1-cyanocyclohexyl)-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H24N4O2S |
|
—— | (2R)-N-cyclopentyl-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]propanamide | —— | C19H25N3O2S |
|
—— | N-[(1R)-1-(4-fluorophenyl)ethyl]-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C21H22FN3O2S |
|
—— | N-benzyl-N-ethyl-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C22H25N3O2S |
|
—— | 1-[(2S,6S)-2,6-dimethylmorpholin-4-yl]-2-(2,4-dimethylphenyl)sulfanylethanone | —— | C16H23NO2S |
|
—— | 1-(2,5-dimethyl-1-prop-2-enylpyrrol-3-yl)-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C22H25N3O2S |
|
—— | 2-[(3,5-dimethyl-1,2-oxazol-4-yl)methylsulfanyl]-5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C17H19N3O2S |
|
—— | (2R)-N-cyclopropyl-2-(2,4-dimethylphenyl)sulfanylpropanamide | —— | C14H19NOS |
|
—— | 2-methyl-5-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1,3,4-oxadiazole | —— | C15H16N4O2S |
|
—— | 2-methylsulfanyl-5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C12H14N2OS |
|
—— | 2-[(3,5-dimethyl-1,2-oxazol-4-yl)methylsulfanyl]-5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazole | —— | C17H19N3O2S |
|
—— | 2-methyl-5-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanylmethyl]-1,3,4-oxadiazole | —— | C15H16N4O2S |
|
—— | 1-[(2S,6R)-2,6-dimethylmorpholin-4-yl]-2-(3,4-dimethylphenyl)sulfanylethanone | —— | C16H23NO2S |
|
—— | N-cyclohexyl-N-methyl-2-[[5-[(2R)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C20H27N3O2S |
|
—— | N-ethyl-N-(2-methylprop-2-enyl)-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C19H25N3O2S |
|
—— | 4-[[(2S)-oxolan-2-yl]methyl]-3-[(1R)-1-phenylethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C15H19N3O2S |
|
—— | (2S)-N-cyclopropyl-2-(2,4-dimethylphenyl)sulfanylpropanamide | —— | C14H19NOS |
|
—— | 1-(2,5-dimethyl-1-prop-2-enylpyrrol-3-yl)-2-[[5-[(2S)-2-phenylpropyl]-1,3,4-oxadiazol-2-yl]sulfanyl]ethanone | —— | C22H25N3O2S |
|
—— | N-cyclohexyl-N-methyl-2-[[5-oxo-4-[[(2R)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-3-yl]sulfanyl]acetamide | —— | C16H26N4O3S |
|
—— | 3-(2-ethoxyethylsulfanyl)-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C11H19N3O3S |
|
—— | 3-anilino-5-(4-chloro-benzylthio)-1,2,4-triazole | 334538-50-0 | C15H13ClN4S |
|
—— | 3-[2-(1-adamantyl)ethylsulfanyl]-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C19H29N3O2S |
|
—— | 3-Methoxy-1-methyl-4-(4-methylsulfanyl-benzyl)-5-trifluoromethyl-1H-pyrazole | —— | C14H15F3N2OS |
|
—— | N-[(1R,2R,3R)-2,3-dimethylcyclohexyl]-2-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide | —— | C17H22N4O2S |
|
—— | N-[(1R)-1-(4-ethylphenyl)ethyl]-2-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide | —— | C19H20N4O2S |
|
—— | N-[(1R)-1-(4-chlorophenyl)ethyl]-2-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide | —— | C17H15ClN4O2S |
|
—— | N-[(1S)-1-(4-fluorophenyl)ethyl]-2-[[5-(2-methylfuran-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]acetamide | —— | C17H16FN3O3S |
|
—— | (2R)-2-[[5-cyclopropyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-(2,2,2-trifluoroethyl)propanamide | —— | C15H17F3N4O2S |
|
—— | 3-[[2-(2-methylanilino)-1,3-thiazol-4-yl]methylsulfanyl]-4-[[(2S)-oxolan-2-yl]methyl]-1H-1,2,4-triazol-5-one | —— | C18H21N5O2S2 |
|
—— | (2S)-2-[[5-cyclopropyl-4-(furan-2-ylmethyl)-1,2,4-triazol-3-yl]sulfanyl]-N-(2,2,2-trifluoroethyl)propanamide | —— | C15H17F3N4O2S |
|
—— | 4-butyl-3-[2-[(2R,6R)-2,6-dimethylmorpholin-4-yl]-2-oxoethyl]sulfanyl-1H-1,2,4-triazol-5-one | —— | C14H24N4O3S |
|
—— | N-[(1S)-1-(4-chlorophenyl)ethyl]-2-[(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide | —— | C17H15ClN4O2S |
|